Endava PLC – (DAVA) Given Consensus Rating of “Hold” by Analysts

Shares of Endava PLC – (NYSE:DAVA) have been given a consensus recommendation of “Hold” by the six analysts that are covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $28.40.

A number of equities research analysts have recently commented on the stock. Credit Suisse Group assumed coverage on shares of Endava in a report on Tuesday, August 21st. They set a “neutral” rating and a $27.00 price target on the stock. Morgan Stanley assumed coverage on shares of Endava in a report on Tuesday, August 21st. They set a “weight” rating and a $29.00 price target on the stock. William Blair assumed coverage on shares of Endava in a report on Tuesday, August 21st. They set an “outperform” rating on the stock. Cowen assumed coverage on shares of Endava in a report on Tuesday, August 21st. They set an “outperform” rating and a $27.00 price target on the stock. Finally, Citigroup assumed coverage on shares of Endava in a report on Tuesday, August 21st. They set a “neutral” rating and a $30.00 price target on the stock.

NYSE:DAVA opened at $24.43 on Thursday. Endava has a 52 week low of $23.00 and a 52 week high of $31.50.

Endava Company Profile

Endava plc provides IT service to finance, insurance and healthcare, retail and consumer goods, telecommunications, media, and technology industries in the United Kingdom. It offers architecture solutions; AI and Intelligent Automation, bots and natural language interfaces, and Robotic Process Automation; software engineering; testing solutions; cloud services; and application management services.

Recommended Story: Technical Analysis of Stocks and What It Means

Analyst Recommendations for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply